{"name": "Iomai Corporation",
 "permalink": "iomai",
 "crunchbase_url": "http://www.crunchbase.com/company/iomai",
 "homepage_url": "http://www.iomai.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": 112,
 "founded_year": 1997,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "301-556-4500",
 "description": "",
 "created_at": "Thu Sep 10 01:51:56 UTC 2009",
 "updated_at": "Thu Sep 10 23:20:32 UTC 2009",
 "overview": "\u003Cp\u003EIomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called transcutaneous immunization (TCI). TCI taps into the unique benefits of a major group of antigen-presenting cells found in the outer layers of the skin to generate an enhanced immune response.\u003C/p\u003E\n\n\u003Cp\u003EIomai is leveraging TCI to enhance the efficacy of existing vaccines, enable new vaccines that are viable only through transcutaneous administration and expand the global vaccine market. \u003C/p\u003E\n\n\u003Cp\u003EThe company was incorporated in 1997 and is based in Gaithersburg, Maryland. Intercell USA, Inc. was formerly known as Iomai Corporation. As a result of the acquisition of Iomai Corporation by Intercell Ag, Iomai Corporation\u0026#8217;s name was changed. As of August 5, 2008, Intercell USA, Inc. operates as a subsidiary of Intercell Biomedical Research \u0026amp; Development AG.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       55],
      "assets/images/resized/0005/9314/59314v2-max-150x150.jpg"],
     [[250,
       92],
      "assets/images/resized/0005/9314/59314v2-max-250x250.jpg"],
     [[253,
       94],
      "assets/images/resized/0005/9314/59314v2-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Gerd",
      "last_name": "Zettlmeissl",
      "permalink": "gerd-zettlmeissl",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Reinhard",
      "last_name": "Kandera",
      "permalink": "reinhard-kandera",
      "image": null}},
   {"is_past": false,
    "title": " President and Director ",
    "person":
     {"first_name": "Thomas",
      "last_name": "Lingelbach",
      "permalink": "thomas-lingelbach",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition":
  {"price_amount": 186460000.0,
   "price_currency_code": "USD",
   "term_code": null,
   "source_url": "",
   "source_description": "Cap Funding Report",
   "acquired_year": 2008,
   "acquired_month": 5,
   "acquired_day": 12,
   "acquiring_company":
    {"name": "Intercell",
     "permalink": "intercell-biomedical-research-development-ag",
     "image":
      {"available_sizes":
        [[[150,
           147],
          "assets/images/resized/0005/9315/59315v1-max-150x150.jpg"],
         [[175,
           172],
          "assets/images/resized/0005/9315/59315v1-max-250x250.jpg"],
         [[175,
           172],
          "assets/images/resized/0005/9315/59315v1-max-450x450.jpg"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "20 Firstfield Road",
    "address2": "Suite 250",
    "zip_code": "20878",
    "city": "Gaithersburg",
    "state_code": "MD",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}